Evidence map›Paper›PMID 31364375›Full record

ArticleAmerican journal of physiology. Renal physiology2019

Perivascular CD73

Heather M Perry, Nicole Görldt, Sun-Sang J Sung, Liping Huang, Kinga P Rudnicka, Iain M Encarnacion, Amandeep Bajwa, Shinji Tanaka, Nabin Poudel, Junlan Yao and 3 more

Abstract read
In one paragraph

Article in American journal of physiology. Renal physiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Article
  3. Pericytes in tissue fibrosis.American journal of physiology. Cell physiology · 2025
    Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Neural transcription factor Pou4f1 promotes renal fibrosis via macrophage-myofibroblast transition.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Heather M PerryDivision of Nephrology and Center for Immunity, Inflammation and Regenerative Medicine, University of Virginia, Charlottesville, Virginia.
Nicole GörldtDivision of Nephrology and Center for Immunity, Inflammation and Regenerative Medicine, University of Virginia, Charlottesville, Virginia.
Sun-Sang J SungDivision of Nephrology and Center for Immunity, Inflammation and Regenerative Medicine, University of Virginia, Charlottesville, Virginia.
Liping HuangDivision of Nephrology and Center for Immunity, Inflammation and Regenerative Medicine, University of Virginia, Charlottesville, Virginia.
Kinga P RudnickaDivision of Nephrology and Center for Immunity, Inflammation and Regenerative Medicine, University of Virginia, Charlottesville, Virginia.
Iain M EncarnacionDivision of Nephrology and Center for Immunity, Inflammation and Regenerative Medicine, University of Virginia, Charlottesville, Virginia.
Amandeep BajwaDivision of Nephrology and Center for Immunity, Inflammation and Regenerative Medicine, University of Virginia, Charlottesville, Virginia.
Shinji TanakaDivision of Nephrology and Center for Immunity, Inflammation and Regenerative Medicine, University of Virginia, Charlottesville, Virginia.
Nabin PoudelDivision of Nephrology and Center for Immunity, Inflammation and Regenerative Medicine, University of Virginia, Charlottesville, Virginia.
Junlan YaoDivision of Nephrology and Center for Immunity, Inflammation and Regenerative Medicine, University of Virginia, Charlottesville, Virginia.
Diane L RosinDepartment of Pharmacology, University of Virginia, Charlottesville, Virginia.ORCID 0000-0003-0187-5717
Jürgen SchraderInstitute of Molecular Cardiology, Heinrich-Heine University Düsseldorf, Düsseldorf, Germany.
Mark D OkusaDivision of Nephrology and Center for Immunity, Inflammation and Regenerative Medicine, University of Virginia, Charlottesville, Virginia.

Funding

Sphingolipids in Acute Kidney Injury and Disease ProgressionR01DK085259 · NIDDK · UNIVERSITY OF VIRGINIA · PI OKUSA, MARK DOUGLAS · 2010 to 2023
$5.0M
Leukocyte Trafficking in Acute Renal FailureR01DK062324 · NIDDK · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI OKUSA, MARK DOUGLAS · 2003 to 2016
$4.4M
Neuroimmune Regulation of Acute Kidney InjuryR01DK123248 · NIDDK · UNIVERSITY OF VIRGINIA · PI Mark Douglas Okusa · 2019 to 2026
$3.3M
Kidney Disease and InflammationT32DK072922 · NIDDK · UNIVERSITY OF VIRGINIA · PI OKUSA, MARK DOUGLAS · 2006 to 2020
$2.6M
Mitochondrial Therapy for Kidney InjuryR01DK117183 · NIDDK · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI BAJWA, AMANDEEP · 2018 to 2022
$1.7M
Sphingosine 1 phosphate receptors 1 and 3 as novel targets in transplantationK01DK091444 · NIDDK · UNIVERSITY OF VIRGINIA · PI BAJWA, AMANDEEP · 2012 to 2016
$579k
MBF Bioscience and Zeiss Microscope System for Stereology and Tissue MorphologyS10RR026799 · NCRR · UNIVERSITY OF VIRGINIA · PI OKUSA, MARK DOUGLAS · 2010 to 2010
$278k
Ischemic Reperfusion injury in Transplantation: Role of Sphingosine 1-phosphate receptors and dendritic cellsR03DK107941 · NIDDK · UNIVERSITY OF VIRGINIA · PI BAJWA, AMANDEEP · 2016 to 2017
$158k
Endothelial sphingosine-1-phosphate receptor 1 regulates renal recovery after acute kidney injuryF32DK108563 · NIDDK · UNIVERSITY OF VIRGINIA · PI PERRY, HEATHER M. · 2015 to 2017
$115k
NCRR NIH HHS S10 RR026799NIDDK NIH HHS F32 DK108563NIDDK NIH HHS K01 DK091444NIDDK NIH HHS R01 DK062324NIDDK NIH HHS R01 DK085259NIDDK NIH HHS R01 DK117183NIDDK NIH HHS R01 DK123248NIDDK NIH HHS R03 DK107941NIDDK NIH HHS T32 DK072922
6 · The paper itself

Abstract

Progressive tubulointerstitial fibrosis may occur after acute kidney injury due to persistent inflammation. Purinergic signaling by 5'-ectonucleotidase, CD73, an enzyme that converts AMP to adenosine on the extracellular surface, can suppress inflammation. The role of CD73 in progressive kidney fibrosis has not been elucidated. We evaluated the effect of deletion of CD73 from kidney perivascular cells (including pericytes and/or fibroblasts of the Foxd1

Indexed as

Cellular Microenvironment5'-NucleotidaseActinsAnimalsCell ProliferationCells, CulturedCollagenDisease Models, AnimalFibroblastsFibrosisForkhead Transcription FactorsGPI-Linked ProteinsInflammation MediatorsKidneyMacrophagesMale5'-NucleotidaseActinsalpha-smooth muscle actin, mouseCollagenForkhead Transcription FactorsFoxd1 protein, mouseGPI-Linked ProteinsInflammation MediatorsNt5e protein, mouseReceptor, Platelet-Derived Growth Factor betaadenosineectonucleotidasefibroblastfolic acidischemia-reperfusionmacrophagepericyte

Identifiers

PMID31364375
PMCPMC6766625

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.